Publications by authors named "Markus Fluck"

Claim this Profile
A
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
Lena Klopp-Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu, Yoshihiro Kuroki, Hong Lu, Markus Fluck

Clin Pharmacol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions.
Robert Hermann, Peter Krajcsi, Markus Fluck, Annick Seithel-Keuth, Afrim Bytyqi

Clin Pharmacokinet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.
Robert Hermann, Peter Krajcsi, Markus Fluck, Annick Seithel-Keuth, Afrim Bytyqi

Clin Pharmacokinet· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION.
Mark S Freedman, Jérôme Wojcik, Kristina H Holmberg, Markus Fluck, Mauro D'Antonio

J Neuroimmunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding.
Hulin Jin, Vittorio D'Urso, Berend Neuteboom, Sean D McKenna, Rene Schweickhardt, Markus Fluck

Oncoimmunology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis.
Robert Hermann, Mats O Karlsson, Ana M Novakovic, Nadia Terranova, Markus Fluck

Clin Pharmacokinet· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis.
Robert Hermann, Mats O Karlsson, Ana M Novakovic, Nadia Terranova, Markus Fluck

Clin Pharmacokinet· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo drug disposition of cilengitide in animals and human.
Hugues Dolgos, Achim Freisleben, Elmar Wimmer, Holger Scheible, Friedrich Krätzer, Markus Fluck

Pharmacol Res Perspect· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition.
Dieter Gallemann, Elmar Wimmer, Constance C Höfer, Achim Freisleben, Markus Fluck

Drug Metab Dispos· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial.
Sonja Krösser, Roland Neugebauer, Hugues Dolgos, Markus Fluck, Karl-Ludwig Rost

Eur J Clin Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis